KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Twist Bioscience (TWST) Net Margin (2018 - 2025)

Historic Net Margin for Twist Bioscience (TWST) over the last 8 years, with Q4 2025 value amounting to 29.46%.

  • Twist Bioscience's Net Margin rose 61500.0% to 29.46% in Q4 2025 from the same period last year, while for Dec 2025 it was 19.57%, marking a year-over-year increase of 401900.0%. This contributed to the annual value of 20.63% for FY2025, which is 460800.0% up from last year.
  • According to the latest figures from Q4 2025, Twist Bioscience's Net Margin is 29.46%, which was up 61500.0% from 27.37% recorded in Q3 2025.
  • Over the past 5 years, Twist Bioscience's Net Margin peaked at 21.22% during Q2 2025, and registered a low of 126.06% during Q1 2022.
  • Moreover, its 5-year median value for Net Margin was 83.15% (2022), whereas its average is 74.54%.
  • In the last 5 years, Twist Bioscience's Net Margin crashed by -336300bps in 2021 and then surged by 1262700bps in 2025.
  • Quarter analysis of 5 years shows Twist Bioscience's Net Margin stood at 108.44% in 2021, then grew by 29bps to 77.1% in 2022, then grew by 22bps to 60.15% in 2023, then soared by 41bps to 35.62% in 2024, then increased by 17bps to 29.46% in 2025.
  • Its Net Margin was 29.46% in Q4 2025, compared to 27.37% in Q3 2025 and 21.22% in Q2 2025.